Palatin Technologies
PTN
#10286
Rank
โ‚น2.30 B
Marketcap
โ‚น1,294
Share price
-0.55%
Change (1 day)
16,567.92%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚น0.4 Billion

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚น8.84 Million. In 2024 the company made an earning of -โ‚น2.57 Billion, an increase over its 2023 earnings that were of -โ‚น3.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น0.4 Billion-84.57%
2024 -โ‚น2.57 Billion-16.9%
2023 -โ‚น3.09 Billion5.99%
2022 -โ‚น2.91 Billion-13.7%
2021 -โ‚น3.38 Billion33.25%
2020 -โ‚น2.53 Billion-172.11%
2019 โ‚น3.50 B2352.33%
2018 โ‚น0.14 B-94.13%
2017 โ‚น2.43 B-154.92%
2016 -โ‚น4.44 Billion3.67%
2015 -โ‚น4.29 Billion878%
2014 -โ‚น0.44 Billion-72.64%
2013 -โ‚น1.6 Billion-33.11%
2012 -โ‚น2.4 Billion77.71%
2011 -โ‚น1.35 Billion
2003 -โ‚น2.28 Billion29.93%
2002 -โ‚น1.76 Billion36.18%
2001 -โ‚น1.29 Billion
1999 -โ‚น1.07 Billion6.04%
1998 -โ‚น1.01 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.470 T-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.394 T-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น75.96 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น1.15 Billion 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น15.56 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.19 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น9.10 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.81 Billion 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5.52 Billion 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA